Psychopharmacology 2025

Psychopharmacology

  • Study of substances that influence brain and behavior.

Objectives

  • Define Psychopharmacology and its components:

    • Pharmacokinetics

    • Pharmacodynamics

    • Different types of drugs: stimulants, depressants, opiates

    • Drug treatments for mental health.

What is Psychopharmacology?

  • Psychopharmacology involves psychoactive drugs that are not naturally occurring in the body but can alter mood, sensation, thinking, or behavior.

  • Drugs may be derived from natural sources or synthesized in a lab.

  • For psychoactive drugs to affect behavior, they must penetrate the brain and influence neurotransmission in various ways.

Importance of Studying Psychopharmacology

  • Provides insight into brain function and the role of various neurotransmitters.

  • Aids in understanding psychiatric disorders and their underlying brain function changes.

  • Supports the development of improved treatments for mental health conditions.

  • Enhances understanding of problematic drug use.

Pharmacokinetics

  • Examines how the body processes drugs and eliminates them.

  • Key processes involved:

    • Absorption: Drug must enter bloodstream to exert effects.

    • Distribution: Drug is disseminated throughout the body to reach its site of action.

    • Metabolism: Converts the drug into compounds for elimination.

    • Elimination: Process of expelling the drug from the body.

Administration Methods

  • Various ways drugs can enter the system:

    • Oral: Most common - must withstand stomach acids and be absorbed in the intestines.

    • Intravenous (IV): Rapid effects but poses risk of overdose.

    • Inhalation: Quick absorption via lungs.

    • Transdermal: Through skin using patches.

    • Intranasal: Directly into nasal cavity, bypassing liver detoxification.

Time Course of Drug Effects

  • Dose-dependent: Effects vary with the amount available at receptor sites.

  • Duration of drug action is influenced by distribution, metabolism, and elimination rates.

Oral Administration Specifics

  • Majority of drugs must dissolve in stomach and survive the acidic environment.

  • The first-pass metabolism can alter drugs as they pass through the liver, affecting potency.

IV Administration Specifics

  • Most precise and rapid method; can lead to life-threatening conditions.

Inhalation Administration Specifics

  • Rapid absorption via lung capillaries leading to quick effects.

  • Risks include lung damage from repeated exposure.

Transdermal and Intranasal Administration Specifics

  • Transdermal through patches for steady absorption.

  • Intranasal allows drugs to bypass the digestive system and enter the bloodstream swiftly.

Absorption - Key Concepts

  • Drugs must be lipid-soluble to cross biological membranes.

  • Movement occurs from areas of high concentration to lower concentration.

Distribution - Key Concepts

  • After entering blood, drugs circulate and bind to tissues.

  • Blood-Brain Barrier (BBB) restricts entry of water-soluble substances while allowing lipid-soluble drugs to cross.

Blood Brain Barrier

  • Selectively permeable; not impermeable to all substances - CTZ allows some substances through to protect the body from toxins.

  • Unique barriers may also exist such as the placental barrier.

Metabolism and Elimination - Key Concepts

  • Drugs must be metabolized to become water-soluble for elimination via urine or other means.

  • The liver is critical for drug metabolism; some drugs can also be excreted through breath or sweat leading to drug testing results.

Half-life

  • Defined as the time needed to reduce the concentration of a drug in the blood by 50%.

  • Different drugs have vastly different half-lives, affecting dosing schedules and detection periods post-consumption.

Pharmacodynamics

  • Examines the effects drugs have on the body.

    • Agonists: Bind to receptors mimicking neurotransmitter effects.

    • Antagonists: Bind to receptors without activating them, blocking neurotransmitter actions.

Drug Categories

  • Psychoactive Drugs: Impact mood and perception.

  • CNS Stimulants: Includes amphetamines and cocaine which increase alertness.

  • CNS Depressants: Includes barbiturates, alcohol, affecting brain activity.

  • Analgesics: Opiates like morphine for pain relief.

  • Hallucinogens: Such as LSD and mescaline affecting sensory perceptions.

Stimulants: Mechanisms

  • Example: Cocaine inhibits reuptake of various neurotransmitters increasing their presence in the synapse.

  • Other stimulants like caffeine work as antagonists to adenosine to facilitate dopamine release.

  • Effects include increased activity, alertness, and mood enhancement.

Depressants: Mechanisms

  • Include substances that reduce arousal by slowing CNS transmission.

  • Alcohol affects coordination, emotional control, and potentially leads to death in excessive doses.

Opiates: Mechanisms and Effects

  • Act primarily by binding to opioid receptors, mimicking the body's natural endorphins, leading to pain relief and euphoria.

  • Risk of tolerance and dependence with continued use.

Opioid Addiction

  • Engagement of brain reward systems fosters addiction; prolonged use alters neurotransmitter levels and creates strong cravings.

Agonist vs. Antagonist

  • Direct Agonist: Drugs that activate receptors directly (e.g., Heroin).

  • Indirect Agonist: Enhance neurotransmitter effects without direct activity (e.g., Cocaine as a reuptake inhibitor).

Narcan: Overdose Reversal

  • An opioid antagonist used to reverse overdoses by displacing opioids from receptors, restoring breathing functions.

The Opioid Crisis

  • Increasing deaths from opioids, exemplified by high death rates in the US compared to other countries.

Hallucinogenic Drugs

  • Alter sensory perceptions and consciousness, examples include LSD and psilocybin.

MDMA Overview

  • Acts as a stimulant and psychedelic; enhances neurotransmitter activity leading to significant psychological effects but can deplete serotonin.

Treatment of Mental Disorders

  • Anxiety: Treated with benzodiazepines and SSRIs targeting several neurotransmitters.

  • Depression: Linked to depletions of serotonin, norepinephrine, and dopamine; treated with SSRIs and SNRIs.

  • Schizophrenia: Characterized by positive (psychotic) and negative symptoms, primarily treated with antipsychotic medications that block dopamine receptors.